MCMCB Pro
J7175

J7175Injection, factor x, (human), 1 i.u.

HCPCSActiveBETOS O1E

J7175 is a HCPCS Level II code for injection, factor x, (human), 1 i.u.. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J7175 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
9000 units
MAI 1 — Line Edit · Prescribing Information
outpatient
9000 units
MAI 1 — Line Edit · Prescribing Information

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J7175

Long descriptor
Injection, factor x, (human), 1 i.u.

The official wording. This is what the code means.

Short descriptor
Inj, factor x, (human), 1iu

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2017

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J7175

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J7175 is not quite right, the correct code is very often within a few positions of it.

  • J7165Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity
  • J7168Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
  • J7169Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg
  • J7170Injection, emicizumab-kxwh, 0.5 mg
  • J7171Injection, adamts13, recombinant-krhn, 10 iu
  • J7172Injection, marstacimab-hncq, 0.5 mg
  • J7173Injection, concizumab-mtci, 0.5 mg
  • J7174Injection, fitusiran, 0.04 mg
  • J7176Injection, human fibrinogen - chmt (fesilty), 1 mg
  • J7177Injection, human fibrinogen concentrate (fibryga), 1 mg
  • J7178Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
  • J7179Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco
  • J7180Injection, factor xiii (antihemophilic factor, human), 1 i.u.
  • J7181Injection, factor xiii a-subunit, (recombinant), per iu
  • J7182Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu
  • J7183Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco

Questions about J7175

What is HCPCS code J7175?

J7175 is a HCPCS Level II code for injection, factor x, (human), 1 i.u.. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J7175?

The CMS HCPCS file marks J7175 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is J7175 paid under the physician fee schedule?

J7175 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026